Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
APS6-45
Cat. No.:
OB0225LY-0068
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
APS6-45 is a compound with anti-inflammatory and anti-tumor activity. It inhibits disease progression by affecting specific signaling pathways.
Synonym:
2188236-41-9; 4-[4-[[2-Fluoro-5-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-(4-(3-(2-Fluoro-5-(perfluoropropan-2-yl)phenyl)ureido)phenoxy)-N-methylpicolinamide; 4-[4-({[2-Fluoro-5-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide
CAS No.:
2188236-41-9
Compound CID:
131953288
Formula:
C23H16F8N4O3
Formula Weight:
548.39
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
APS6-45 can be used in chronic inflammation and tumor research.
Library Information
Targets:
MAPK; Ras
Pathways:
GPCR/G protein; MAPK
Plate Number:
AOCL-1
Plate Location:
g10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
240 mg/mL; 437.67 mM
